Yıl: 2006 Cilt: 59 Sayı: 3 Sayfa Aralığı: 115 - 118 Metin Dili: Türkçe

Miyokard perfüzyon sintigrafisi

Öz:
Gelişmiş ve gelişmekte olan ülkelerin çoğunda en sık ölüm nedeni kardiyovasküler hastalıklardır. Miyokard perfüzyon sintigrafisi (MPS) koroner arter hastalığı tanı ve prognoz belirlenmesinde, viabilite tanımlanmasında ve revaskülarizasyon sonrası iyileşmenin değerlendirilmesinde günümüzde nükleer kardiyolojide en sık uygulanan işlemdir. Bu yazıda MPS’nin tekniği, miyokardial radyofarmasötik ajanlar, stres protokolleri, yorumu etkileyen faktörler ve MPS’nin prognostik değeri incelenmiştir.
Anahtar Kelime: Koroner arter hastalığı Tanı teknikleri, kalp damar Tanı teknik ve işlemleri Miyokardiyal perfüzyon görüntüleme

Myocardial perfusion scintigraphy

Öz:
Cardiovascular diseases remain the principal cause of death in the majority of developed and in developing countries. Myocardial perfusion scintigraphy (MPS) is currently most performed procedure in nuclear cardiology for diagnosis and prognosis of coronary artery disease, the characterisation of viability and the assessment of potential recovery after coronary revascularisation. This manuscript reviews the technique of MPS, myocardial radiopharmaceutical agents, stress protocols, the factors influencing the interpretation and the prognostic value of MPS.
Anahtar Kelime: Coronary Artery Disease Myocardial Perfusion Imaging Diagnostic Techniques and Procedures Diagnostic Techniques, Cardiovascular

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Gould K, Lipscomb K. Effects of coronary stenosis on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55. 2. Upton MT, Rerych SK, Newman GE, et al. Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation 1980;62:341-9. 3. Bonow RO, Bacharach SL, Green MV, et al. Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography. Circulation 1981;64:315-23. 4. Zaret BL, Wackers FJ. Nuclear Cardiology (1): Review Article. N Engl J Med 1993; 329:775-83. 5. Dilsizian V, Rocco TP, Freedman NMT, et al. Enhanced detection of ischemic but viable myocardium by the reinjection of Thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146. 6. DePuey EG, Berman DS, Garcia EV. Cardiac SPECT imaging. Philadelphia: Lippincott-Raven; 1996. 7. Leppo J, Meerdink D. Comparison of the myocardial uptake of a technetium-labeled isonitrile analog and thallium. Circ Res 1989;65:632-9. 8. Montz R, Perez-Castejon MJ, Jurado JA, et al. A Spanish- Portuguese multicentre clinical trial: Technetium-99m tetrofosmin rest/ stress myocardial SPET with a same day 2 hour protocol: comparison with coronary angiography. Eur J Nucl Med 1996; 23:639-47. 9. Machac J, Henzlova MJ. Basis of myocardial perfusion, metabolism, infarction, and receptor imaging in coronary artery disease and congestive heart failure. The pathophysiologic basis of nuclear medicine. Elgazzar AH (ed). Springer Verlag Berlin, 2001. p: 221-257. 10. Rochmis P, Blackburn H. Exercise tests. A survey of procedures, safety and litigation experience in approximately 170,000 tests. JAMA 1971;217:1061-6. 11. Cerqueira MD, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384-9. 12. Klodas E, Miller TD, Christian TF, et al. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003;10:4-8. 13. Travain MI, Wexler JP. Pharmacological stress testing. Semin Nucl Med 1999; 29:298-318. 14. Samady H, Wackers FJ, Joska TM, et al. Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise. J Nucl Cardiol 2002;9:188-96. 15. Kirch D, Koss J, Bublitz T, et al. False-positive findings on myocardial perfusion SPECT.J Nucl Med. 2004 Sep;45(9):1597. 16. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905–14. 17. Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1486–9. 18. Weiss AT, Berman DS, Lew AS, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752–9. 19. Gioia G, Milan E, Giubbini R, et al. Prognostic value of tomographic restredistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996;3:150–6. 20. Newhouse HK, Wexler JP. Myocardial perfusion imaging for evaluating interventions in coronary artery disease. Semin Nucl Med. 1995;25:15-27.
APA TÜRKÖLMEZ Ş (2006). Miyokard perfüzyon sintigrafisi. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 59(3), 115 - 118.
Chicago TÜRKÖLMEZ Şeyda Miyokard perfüzyon sintigrafisi. Ankara Üniversitesi Tıp Fakültesi Mecmuası 59, no.3 (2006): 115 - 118.
MLA TÜRKÖLMEZ Şeyda Miyokard perfüzyon sintigrafisi. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol.59, no.3, 2006, ss.115 - 118.
AMA TÜRKÖLMEZ Ş Miyokard perfüzyon sintigrafisi. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2006; 59(3): 115 - 118.
Vancouver TÜRKÖLMEZ Ş Miyokard perfüzyon sintigrafisi. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2006; 59(3): 115 - 118.
IEEE TÜRKÖLMEZ Ş "Miyokard perfüzyon sintigrafisi." Ankara Üniversitesi Tıp Fakültesi Mecmuası, 59, ss.115 - 118, 2006.